241 related articles for article (PubMed ID: 26267732)
21. Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs.
Elewski BE; Ghannoum MA; Mayser P; Gupta AK; Korting HC; Shouey RJ; Baker DR; Rich PA; Ling M; Hugot S; Damaj B; Nyirady J; Thangavelu K; Notter M; Parneix-Spake A; Sigurgeirsson B
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):287-94. PubMed ID: 22181693
[TBL] [Abstract][Full Text] [Related]
22. Access of efinaconazole topical solution, 10%, to the infection site by spreading through the subungual space.
Elewski BE; Pollak RA; Pillai R; Olin JT
J Drugs Dermatol; 2014 Nov; 13(11):1394-8. PubMed ID: 25607708
[TBL] [Abstract][Full Text] [Related]
23. Efinaconazole solution 10% for treatment of toenail onychomycosis in Latino patients.
Cook-Bolden FE; Lin T
Cutis; 2017 Apr; 99(4):286-289. PubMed ID: 28492600
[TBL] [Abstract][Full Text] [Related]
24. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.
Gupta AK; Fleckman P; Baran R
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S70-80. PubMed ID: 11051136
[TBL] [Abstract][Full Text] [Related]
25. Report of a case of a dermatophytoma successfully treated with topical efinaconazole 10% solution.
Cantrell W; Canavan T; Elewski B
J Drugs Dermatol; 2015 May; 14(5):524-6. PubMed ID: 25942674
[TBL] [Abstract][Full Text] [Related]
26. Efinaconazole 10% nail solution: a new topical treatment with broad antifungal activity for onychomycosis monotherapy.
Gupta AK; Paquet M
J Cutan Med Surg; 2014; 18(3):151-5. PubMed ID: 24800702
[TBL] [Abstract][Full Text] [Related]
27. Efinaconazole solution 10%: topical antifungal therapy for toenail onychomycosis.
Tosti A
Cutis; 2013 Oct; 92(4):203-8. PubMed ID: 24195094
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of combination therapy with efinaconazole 10% solution and 1064 nm Nd:YAG laser for treatment of toenail onychomycosis.
Bonhert K; Dorizas A; Sadick NS
J Cosmet Laser Ther; 2019; 21(3):179-183. PubMed ID: 30052090
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: A multicenter, single-arm study.
Iozumi K; Abe M; Ito Y; Uesugi T; Onoduka T; Kato I; Kato F; Kodama K; Takahashi H; Takeda O; Tomizawa K; Nomiyama T; Fujii M; Mayama J; Muramoto F; Yasuda H; Yamanaka K; Sato T; Oh-I T; Kasai H; Tsuboi R; Hattori N; Maruyama R; Omi T; Shimoyama H; Sei Y; Nakasu I; Nishimoto S; Hata Y; Mochizuki T; Fukuzawa M; Seishima M; Sugiura K; Katayama I; Yamamoto O; Shindo M; Kiryu H; Kusuhara M; Takenaka M; Watanabe S
J Dermatol; 2019 Aug; 46(8):641-651. PubMed ID: 31206779
[TBL] [Abstract][Full Text] [Related]
30. The Presence of an Air Gap Between the Nail Plate and Nail Bed in Onychomycosis Patients: Treatment Implications for Topical Therapy.
Gupta AK; Pillai R
J Drugs Dermatol; 2015 Aug; 14(8):859-63. PubMed ID: 26267730
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
Tavakkol A; Fellman S; Kianifard F
Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
[TBL] [Abstract][Full Text] [Related]
32. Topical therapy for toenail onychomycosis: an evidence-based review.
Gupta AK; Daigle D; Foley KA
Am J Clin Dermatol; 2014 Dec; 15(6):489-502. PubMed ID: 25257931
[TBL] [Abstract][Full Text] [Related]
33. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
Gupta AK; Lynde CW; Konnikov N
J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
[TBL] [Abstract][Full Text] [Related]
34. A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis.
Gupta AK; Leonardi C; Stoltz RR; Pierce PF; Conetta B;
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):437-43. PubMed ID: 15987289
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies.
Elewski BE; Aly R; Baldwin SL; González Soto RF; Rich P; Weisfeld M; Wiltz H; Zane LT; Pollak R
J Am Acad Dermatol; 2015 Jul; 73(1):62-9. PubMed ID: 25956661
[TBL] [Abstract][Full Text] [Related]
36. A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis.
Sigurgeirsson B; van Rossem K; Malahias S; Raterink K
J Am Acad Dermatol; 2013 Sep; 69(3):416-25. PubMed ID: 23706639
[TBL] [Abstract][Full Text] [Related]
37. Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.
Lahfa M; Bulai-Livideanu C; Baran R; Ortonne JP; Richert B; Tosti A; Piraccini BM; Szepietowski JC; Sibaud V; Coubetergues H; Voisard JJ; Paul C
Dermatology; 2013; 226(1):5-12. PubMed ID: 23467055
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study.
Watanabe S; Kishida H; Okubo A
J Dermatol; 2017 Jul; 44(7):753-759. PubMed ID: 28332720
[TBL] [Abstract][Full Text] [Related]
39. Topical Treatment of Onychomycosis and Clinically Meaningful Outcomes.
Gupta AK; Korotzer A
J Drugs Dermatol; 2016 Oct; 15(10):1260-1266. PubMed ID: 27741345
[TBL] [Abstract][Full Text] [Related]
40. Topical efinaconazole: A promising therapeutic medication for tinea unguium.
Noguchi H; Matsumoto T; Hiruma M; Asao K; Hirose M; Fukushima S; Ihn H
J Dermatol; 2018 Oct; 45(10):1225-1228. PubMed ID: 30035311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
